Advertisement
Research ArticleGastrointestinal, Hepatic, Pulmonary, and Renal
Open Access

The GPR40 Full Agonist SCO-267 Improves Liver Parameters in a Mouse Model of Nonalcoholic Fatty Liver Disease without Affecting Glucose or Body Weight

Mitsugi Ookawara, Keisuke Matsuda, Masanori Watanabe and Yusuke Moritoh
Journal of Pharmacology and Experimental Therapeutics October 2020, 375 (1) 21-27; DOI: https://doi.org/10.1124/jpet.120.000046

Article Information

vol. 375 no. 1 21-27
DOI 
https://doi.org/10.1124/jpet.120.000046
PubMed 
32719069
Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0022-3565
Online ISSN 
1521-0103
History 
  • Received April 11, 2020
  • Accepted July 21, 2020
  • Published online September 12, 2020.

Article Versions

Copyright & Usage 
Copyright © 2020 The Author(s) This is an open access article distributed under the CC BY Attribution 4.0 International license.

Author Information

  1. Mitsugi Ookawara,
  2. Keisuke Matsuda,
  3. Masanori Watanabe, and
  4. Yusuke Moritoh
  1. SCOHIA PHARMA, Inc., Kanagawa, Japan
  1. Address correspondence to:
    Yusuke Moritoh, Research and Development Division, SCOHIA PHARMA, Inc., 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa 251-8555, Japan. E-mail: yusuke.moritoh{at}scohia.com
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: July 2020 to February 2023

AbstractFullPdf
Jul 20201820164
Aug 20202260118
Sep 202028410385
Oct 20202119290
Nov 2020185942
Dec 2020256561
Jan 2021217553
Feb 2021227545
Mar 2021244635
Apr 2021133435
May 2021325140
Jun 2021294635
Jul 2021303630
Aug 2021373929
Sep 202144337
Oct 202174151
Nov 2021324034
Dec 202153831
Jan 2022133253
Feb 2022103328
Mar 202204625
Apr 202253844
May 202295334
Jun 202233321
Jul 202293613
Aug 2022136046
Sep 202255650
Oct 202282931
Nov 202243227
Dec 2022134832
Jan 202384827
Feb 2023061

Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools

Research ArticleGastrointestinal, Hepatic, Pulmonary, and Renal

GPR40 Full Agonist for Nonalcoholic Fatty Liver Disease

Mitsugi Ookawara, Keisuke Matsuda, Masanori Watanabe and Yusuke Moritoh
Journal of Pharmacology and Experimental Therapeutics October 1, 2020, 375 (1) 21-27; DOI: https://doi.org/10.1124/jpet.120.000046
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo

Jump to section

Advertisement